Wasatch Advisors LP Invests $29.18 Million in Billiontoone, Inc. $BLLN

Wasatch Advisors LP acquired a new stake in Billiontoone, Inc. (NASDAQ:BLLN) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 369,638 shares of the company’s stock, valued at approximately $29,179,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Baillie Gifford & Co. acquired a new stake in Billiontoone in the 4th quarter worth about $103,786,000. Massachusetts Financial Services Co. MA acquired a new position in shares of Billiontoone during the 4th quarter valued at about $13,373,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Billiontoone during the 4th quarter valued at about $1,348,000. UBS Group AG purchased a new position in shares of Billiontoone during the 4th quarter worth about $2,586,000. Finally, Adams Street Partners LLC purchased a new position in shares of Billiontoone during the 4th quarter worth about $140,063,000.

Billiontoone Stock Performance

Billiontoone stock opened at $118.17 on Friday. The stock’s 50-day moving average is $92.57 and its 200-day moving average is $87.32. The company has a market cap of $5.43 billion and a price-to-earnings ratio of 214.85. The company has a debt-to-equity ratio of 0.18, a current ratio of 10.92 and a quick ratio of 10.58. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $138.70.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.33. The firm had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. During the same period in the prior year, the firm earned ($0.39) earnings per share. The business’s revenue for the quarter was up 83.8% on a year-over-year basis. Equities analysts anticipate that Billiontoone, Inc. will post 0.93 earnings per share for the current year.

Insider Transactions at Billiontoone

In other Billiontoone news, insider Nancy Joann Johnson sold 10,582 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the completion of the sale, the insider directly owned 21,900 shares in the company, valued at $2,200,293. The trade was a 32.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Oguzhan Atay sold 26,250 shares of the stock in a transaction on Monday, June 8th. The stock was sold at an average price of $97.66, for a total transaction of $2,563,575.00. Following the completion of the sale, the insider directly owned 20,000 shares of the company’s stock, valued at $1,953,200. The trade was a 56.76% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 91,582 shares of company stock valued at $9,192,361 in the last three months.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on BLLN shares. BTIG Research lowered their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday. Wells Fargo & Company decreased their price target on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. JPMorgan Chase & Co. boosted their price objective on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Finally, Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $125.29.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.